Aim To understand the scope for improving children's glycaemic outcomes by reducing variation between clinics and examine the role of insulin regimen and clinic characteristics.
Introduction
The UK has the fourth largest paediatric diabetes population in Europe and the fifth largest population in the world [1, 2] , with the most recent estimates indicating that at least 29 000 children aged under 19 years have Type 1 diabetes in the country [3, 4] . Over the last decade, governmental bodies and national organizations have set specific standards of care for children with diabetes in the UK [5] [6] [7] [8] . However, performance of England and Wales is poor when compared with similar European countries [9] [10] [11] . In 2012, fewer than one in five children and young people with diabetes in England and Wales met the National Institute for Health and Care Excellence (NICE) recommended HbA 1c target of < 58 mmol/mol (7.5%) [12] . Results from the 2012 NHS Diabetes Atlas of Variation reported wide regional variations in diabetes outcomes for children, thus identifying the issue of unwarranted variation in paediatric diabetes care [13] . National audit reports have supported these findings by describing consistently large differences between paediatric diabetes clinics [14] . Reduction of clinic variations was identified as a clear priority in the 2012 National Paediatric Diabetes Service Improvement Delivery Plan, which also set an aim to reduce national levels of HbA 1c by 16 mmol/mol (1.5%) by 2023 [15] .
Several multicentre studies have looked at glycaemic differences between paediatric clinics [16] [17] [18] [19] [20] [21] [22] [23] . However, one major obstacle to effective policy action regarding clinic variation, as explored in previous studies, is that it is conceptualized as absolute differences between clinic means. In addition to that, we need to consider the share of the total variation in the glycaemic control that exists between clinics [24, 25] . This idea corresponds to the concept of clustering [26] . Understanding how health outcomes are geographically clustered in the population is of crucial importance for policy development and implementation [27] . For example, if children's metabolic control is achieved uniformly across clinics (low clustering), then policies aiming to reduce centre variation by targeting low performing clinics may narrowly miss most poorly controlled children in the country. Conversely, if glycaemic outcomes are distributed heterogeneously across clinics (high clustering), then policies that target all clinics in the country will see many resources inefficiently delivered to areas at the smallest need.
The overall aim of the current study was therefore to determine the scope for improving children's glycaemic outcomes by reducing variation between clinics. More specifically, the objectives were to describe the extent of variation in glycaemic control between and within clinics; explore the general contribution of clinics to understanding differences in children's glycaemic outcomes; determine whether the influence of clinic context can be explained by differences in insulin regimen or characteristics of the clinics, and investigate how clinic characteristics are associated with children's metabolic control.
Methods

Study design and population
We conducted a secondary analysis of nationwide data from the National Paediatric Diabetes Audit (NPDA) -the national audit of diabetes care for children and young people in England and Wales. Diabetes clinics are organized into 11 regional Paediatric Diabetes Networks (10 in England plus Wales). The study included all children aged < 19 years with Type 1 diabetes who received care in paediatric diabetes clinics in England and Wales between 1 April 2012 and 31 March 2013 [14] . We included children with a duration of diabetes of at least 3 months because levels of HbA 1c immediately adjacent to diagnosis are not reflective of ongoing diabetes control. We excluded 251 children who changed clinic during the audit year and children with missing information on age (n = 3), gender (n = 9), ethnicity (n = 121), deprivation (n = 190) and duration of diabetes (n = 208). Clinics were included if they had at least 10 children. Adoption of this threshold reflected the need to keep a balance between excluding as few clinics as possible and excluding clinics for which the amount of data was too small to be representative. One clinic with one eligible child was excluded leaving a final study population of 21 773 children across 176 clinics.
NPDA has approval from the Confidentiality Advisory Group of the Health Research Authority to collect patient data under section 251 of the NHS Act 2006 (Reference No: ECC 2-03 (c)/2012). No additional ethics approval was required.
Measures
Outcome variable
Glycaemic control was assessed by levels of HbA 1c reported in standardized concentrations of mmol/mol in accordance with the International Federation of Clinical Chemistry (IFCC) [28] . The mean HbA 1c value over the audit year for each patient was used in the current analyses.
Case-mix variables
To ensure a fair comparison between clinics, we adjusted our analyses for glycaemic determinants that are beyond the control of the clinic [29] . These included age (continuous variable), gender, duration of diabetes (four categories: < 1 year, 1 year, 2-4 years and ≥ 5 years), ethnicity (six categories: white, mixed, Black, Asian, other, 'not reported'), and deprivation (five quintiles). Deprivation was derived by linking patient postcodes to the 2010 and 2011 Indices of Multiple Deprivation (IMD) for England [30] and Wales [31] respectively. The IMD combines information from several domains (income, employment, education, health, housing and services, crime, and living environment) to produce a single score which is a relative ranking of small areas. An adjusted UK-wide IMD score was generated following established methodology [32] . Interaction terms between age and diabetes duration contributed significantly to the explanatory power of the model and were retained in the models.
Insulin regimen and clinic characteristics
We considered four factors related to diabetes care; one measured at individual level (insulin regimen) and three at the level of the clinic (regional network, clinic volume and
What's new?
• This is the first population-based study to quantify the impact of clinic context on glycaemic control in children with Type 1 diabetes in the UK using robust multilevel techniques.
• Overall, children who attended clinics with less variable glycaemic results had better glycaemic control.
• There were noticeable differences in HbA 1c between diabetes clinics over and above individual characteristics. However, glycaemic control varied more within rather than between clinics and interventions targeting only poor clinics would fail to capture most children in need.
• Glycaemic improvements might best be achieved by not only reducing clinic variation, but also shifting the whole distribution of clinics to higher levels of quality.
ª 2017 Diabetes UK within-clinic glycaemic variability). Insulin regimen was classified as ≤ 3 injections/day, ≥ 4 injections/day and insulin pump therapy. For each clinic, we also computed three variables; these included the regional network to which the clinic belongs, the total number of eligible children being served by the clinic (clinic volume), and the standard deviation of HbA 1c measurements (within-clinic HbA 1c variability). Data for insulin regimen were missing for 2933 children (13.5%). To minimize loss of information, missing data on insulin regimen were imputed using multiple imputation chained equations under a missing at random assumption [33] . Imputed results were broadly similar to those using observed values (see File S1); in the analysis examining the role of insulin regimen imputed findings are presented in this paper.
Statistical analysis
We split variation in HbA 1c into variation between clinics and variation within clinics (i.e. between children) using a two-level multilevel model [26] . We also adjusted for children's case-mix characteristics as fixed effects. To visualize variation between adjusted clinic means, we plotted clinic estimates with 95% confidence intervals (95% CI) derived from the adjusted two-level model. The above clinic estimates are akin to comparing clinics as if they had the same case-mix profile of children. Clinic estimates incorporate a 'shrinkage factor' to correct for random variation, with less precise estimates from small clinics being weighted towards the national average. Clinics for which the upper 95% CI limit was lower than the national average were considered as performing 'better than average', whereas clinics whose lower 95% CI limit exceeded the national average were classified as 'poorer than average'. Finally, clinics whose CI limits crossed the national average were categorized as 'average'. To better understand the scope for improvements in glycaemic outcomes, we need to consider variation between clinics relative to the total variation (i.e. between and within clinics) [24, 25, 34] . To explore this, we calculated the intraclass correlation coefficient (ICC) which represents the proportion of total variation in glycaemic control which occurs between clinics, i.e. ICC ¼ between clinic variance between clinicþ within clinic variance [35] . To illustrate the potential of a clinic-based approach to improve glycaemic control at a national level, we calculated the proportion of children with good (< 58 mmol/mol; 7.5%), moderate (58-80 mmol/mol; 7.5-9.5%) and poor glycaemic control (> 80 mmol/mol; 9.5%) in each of the three clinic classifications identified by the two-level case-mix adjusted model.
Having established the share of total variation in HbA 1c that exists between clinics, we sought to investigate whether service-related factors could explain the 'effect' of clinic context on glycaemic outcomes. To explore this aspect, we extended the two-level case-mix adjusted model by separately introducing individual insulin regimen, regional network structure, clinic volume and clinic HbA 1c -SD and looking at changes in ICC. Attenuation of the relative clinic effect was judged by reduction in ICC. We also examined how the above factors are related to children's glycaemic outcomes. Clinic volume and HbA 1c -SD were entered simultaneously into the model because larger clinics are more likely to exhibit greater variability. Inclusion of quadratic terms for clinic volume and HbA 1c -SD did not improve model fit indicating that their association with glycaemic control was adequately described as linear.
Parameters were estimated using the maximum likelihood method. Model fit was examined by using the likelihood ratio test (LRT). Distribution of individual and clinic-level residuals were checked in all models and showed approximate normality. Statistical analyses were performed using Stata 13.
Results
Extent of variation in glycaemic control between and within clinics
The characteristics of children and clinics are presented in Table 1 . Clinic volume ranged from 34 to 398 children. Clinic means are represented by the red diamond and their spread around the national average value of 72 mmol/mol (8.8%) indicates the degree of variability that exists between clinics. Two things are worth noticing. First, glycaemic control varies more within than between clinics, resulting in a considerable overlap between the clinic individual distributions. Second, clinics with poorer average glycaemic performance tend to have children with more variable glycaemic outcomes. Figure 2 shows the estimates of clinic means with 95% CI derived from the two-level case-mix adjusted model. On average, adjusted clinic means deviated around the national average by 3.5 mmol/mol (0.3%). Clinics in the bottom 2.5% of the distribution had a glycaemic difference of around 14 mmol/mol [1.3%] compared with clinics located in the top 2.5%. Overall, 69 of the 176 practices (39%) had an adjusted HbA 1c value that deviated significantly from the national average. Of these, 34 practices performed below average and 35 performed above average.
General contribution of clinics to total variation in glycaemic control
To address the contribution of clinics in explaining variation in children's glycaemic outcomes, the proportion of the total variation that is located between clinics (i.e. ICC) was calculated ( Table 2 ). The unadjusted model showed that only 5.4% of the total variation occurred between clinics. After controlling for individual case-mix characteristics, ICC reduced slightly to 4.7%, with the remaining variation (95.3%) being located within clinics. Table 3 shows how children with different levels of glycaemic control are distributed across clinics. Of the 5333 children with poor glycaemic control, 1546 (28%) received their care in one of the 35 clinics with a poorer than average performance. Although this is higher than the 19% expected by chance, most poorly controlled children (72%) were treated by nonpoorly performing clinics.
Insulin regimen and clinic characteristics
As shown in Table 2 , ICC was affected only marginally when insulin regimen and clinic volume were fitted in the case-mix adjusted model (ICC slightly reduced to 4.2% and 4.5% respectively). Inclusion of network structure in the model led to a moderate reduction in ICC to 4.2%; however, addition of networks did not give a better fit to the national data compared with the case-mix adjusted model (P-value of LRT = 0.06). By contrast, addition of HbA 1c -SD explained almost half of the clinic variability leading to a substantial reduction in ICC to 2.4%. Detailed results from all models are shown in Table S1 .
We further explored the association of HbA 1c with clinic characteristics after controlling for children's case-mix profile. Figure 3 shows the predicted mean HbA 1c values for each of the 11 networks. Although some significant differences between networks are noticed (e.g. East Midlands and South Central vs. East of England), overall, there is a substantial overlap in their confidence intervals. 
Discussion
This study explored the importance of clinic context for understanding glycaemic differences in children with Type 1 diabetes. To convey the magnitude of potentially unwarranted variation between diabetes practices, we first examined glycaemic differences between clinics after adjusting for the case-mix composition of clinics. We showed that two of five practices had a glycaemic performance that differed significantly from the national average, and that practices with typically good glycaemic control had a glycaemic difference of 14 mmol/mol (1.3%) compared with practices with a typically poor glycaemic performance. We also expressed practice variation as a proportion of the total variability in glycaemic outcomes. This allowed us to better understand the scope for glycaemic improvements that might be possible by reducing variation between clinics. We found that clinics explained only a small portion of the total variation in glycaemic control (i.e. 4.7%) and that most of the variation was within clinics and potentially attributable to unmeasured patient characteristics.
From a health policy perspective, focusing on absolute differences between clinic average values provides insufficient information. Rather, it is important to consider clinic variation as a share of the total variability in HbA 1c [24, 25, 34] . For example, it is possible to have quite large differences between clinics and still show a low ICC if the variation that occurs within clinics is sufficiently large. This A UK-wide index of multiple deprivation score for both England and Wales was developed using England as a reference population and following methodology described by Payne and Abel [32] . Note: percentages may not add up to 100 due to rounding.
ª 2017 Diabetes UK is precisely the situation revealed in our study. We showed that interventions targeting only poor clinics would fail to capture most children in need because they are distributed quite unvaryingly across clinics. Although reduction of practice variations should always be a strategic goal of diabetes systems, our findings suggest that nationwide improvements in glycaemic control might best be achieved by not only targeting poor performers, but also focusing on children with poor glycaemic control all over the country. That is, shifting the whole distribution of clinics to higher levels of quality. The recent change in NICE guidelines for children with Type 1 diabetes towards tighter HbA 1c targets of < 48 mmol/mol (6.5%) in 2015 [36] could potentially help towards this direction. Patient-centred policies have also been shown to facilitate whole system improvements [37] .
Here, the introduction of patient-reported experience measures (PREM) in England and Wales in 2013 [38] can be used as an effective tool to encourage local changes in all clinics, even those identified as performing well.
To gain a better insight into how clinic context might impact on glycaemic outcomes we further examined the role of factors related to diabetes care. First, we showed that insulin regimen had a small impact on ICC. This is consistent with other studies which also found that clinic differences could not be explained by type and dose of insulin treatment [17, 18, 20] . This suggests that aspects of diabetes care other than insulin regimens on offer might explain how clinics contribute to differences in children's metabolic control. We also found that the contribution of regional networks on children's glycaemic control was limited after controlling for 
FIGURE 2
Estimates of clinic means with 95% confidence intervals after adjustment for differences in case-mix characteristics of children regarding age, gender, diabetes duration, ethnicity and deprivation. Estimates derived from a two-level model with a random effect for clinic and incorporate a 'shrinkage factor' to correct for random variation, with less precise estimates from small clinics being weighted towards the national average (red horizontal line). The dashed line represents the NICE HbA 1c recommended target at the time of the study. ICC = 4.7%. ICC represents the proportion of total variation in HbA 1c which occurs between clinics. children and clinic differences. It is important to emphasize that this finding does not indicate that regional networks have no important role to play in the way diabetes care is structured and delivered; instead networks could provide an efficient arena for the implementation of national guidelines and dissemination of interventions, by encouraging young people and carer participation, broadening of stakeholder engagement, mapping resources and staffing levels, and identifying areas of service improvement [39] .
We also found that children treated in larger clinics had better glycaemic control, regardless of their case-mix characteristics. This might reflect a tendency for larger clinic size to provide more specialized care. However, a reduction of 0.9 mmol/mol per additional 100 children was of little clinical significance. We also found that clinic size explained only a small proportion of the 'clinic effect'. Taken together, these findings suggest that there are unlikely to be any meaningful effects from centralization of paediatric diabetes units into higher volume centres.
We explicitly modelled within-clinic variability as a cliniclevel variable and found that, overall, children who attended clinics with more consistent glycaemic results had significantly better glycaemic control. This finding is in line with results from the Hvidore Study Group who reported better glycaemic performance in centres where the multidisciplinary team set consistent glycaemic targets [30] . We also found that within-clinic variability explained half of the clinic differences. Glycaemic consistency requires focusing attention on the management of challenging populations of children and echoes a broad range of factors, including team cohesiveness, coordination of care and goal setting. Our data suggest that achievement of glycaemic consistency within a clinic could be used as a separate performance indicator in addition to average glycaemic levels. This is the first study to quantify the impact of clinic context on glycaemic control of children with Type 1 diabetes. We used a multilevel analytical approach which provides a robust framework for analysing hierarchical data. The large number of clinics provided high power to test for random effects. Also, the use of national audit data means the results of our study have strong external validity and are directly relevant to clinical practice.
Our results should be interpreted in the context of potential limitations. First, this was a cross-sectional analysis which precludes us from making any causal inferences. Although an effort was made to adjust for important glycaemic determinants that are exogenous to the clinic environment, other unmeasured factors such as family environment, parental education, prevalence of comorbidities and health-risk behaviours were not taken into account. Moreover, because no individual-level indicators of socioeconomic status were available, we used small-area deprivation as a proxy variable, which might have led to residual confounding. In this regard, attribution of residual clinic differences to differences in quality of diabetes care should be done with caution [40] . Second, the use of routinely collected data meant we had no control over potential errors during data collection or data entry. Third, children attending the same clinic might also come from the same neighbourhood in which case 'clinic effects' might partly reflect the existence of underlying 'small-area effects'. To explore this, crossclassified models were constructed, but the proportion of variance at the level of the clinic remained unaffected. Finally, although HbA 1c measurements were based on standardized values, variation due to differences in laboratory methods between clinics cannot be excluded.
Conclusion
We analysed national audit data from children with Type 1 diabetes in England and Wales and found that clinic differences accounted for only a small portion of the total variation in glycaemic control because most of the variation was within clinics. This implies that quality improvement might best be achieved by not only targeting poor centres, but also 'shifting the curve' of overall paediatric diabetes practice towards higher quality levels.
